Zealand Pharma

Director's Dealing • Dec 5, 2025

{0}------------------------------------------------

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Henriette Wennicke
2.	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amend ment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc tion monitor
a)	Name	Zealand Pharma A/S
b)	LEI	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Ordinary shares.
	Identification code	DK0060257814
b)	Nature of the transaction	Vesting of Performance Share Units and receipt of ordinary shares in this context.
c)	Price(s) and volume(s)	Price(s) DKK 487.60	Volume(s) 15,442
d)	Aggregated information
	- Aggregated volume	15,442
	- Price	DKK 7,529,519.20
e)	Date of the transaction	2025-12-02
f)	Place of the transaction	Outside a trading venue, XOFF